FRANCE – Carmat, the designer and developer of the world’s most advanced total artificial heart, has had the first implantation of its bioprosthetic artificial heart, Aeson in the United States within the framework of the Early Feasibility Study (EFS). The implant procedure was performed by a team led by Dr. Jacob N. Schroder and Dr. Carmelo A. Milano, heart surgeons at Duke University Hospital, in Durham, North Carolina. It is the first U.S. hospital to implant Aeson within the framework of the EFS. Three additional U.S. centers are fully trained…
Read MoreUSA conducts its first artificial heart implant using Carmat’s Aeson
